Dr. Darbari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 202-476-5000
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- The MetroHealth System/Case Western Reserve UniversityResidency, Pediatrics, 1994 - 1997
- Gandhi Medical CollegeClass of 1986
Certifications & Licensure
- MD State Medical License 1997 - 2026
- DC State Medical License 1998 - 2024
- OH State Medical License 1996 - 1998
- UT State Medical License 1996 - 1998
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Natural History of Sickle Cell Disease Start of enrollment: 2004 Apr 29
Roles: Contact
Publications & Presentations
PubMed
- Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse L C Lobo, Swee Lay Thein
The Lancet. Haematology. 2024-12-04 - 1 citationsOptimising the screening for haemoglobinopathies in pregnancy planning.Robert S Nickel, Deepika S Darbari, Brenda Martin, Lisa Thaniel, Harvey Stern
Human Fertility. 2023-12-01 - Feasibility and preliminary efficacy of the Balance Program to reduce pain-related disability in pediatric sickle cell disease.Megan E Connolly, Sydney Forman, Christina M Sharkey, Stephanie Merwin, Deepika S Darbari
Pediatric Blood & Cancer. 2023-12-01
Journal Articles
- Graph Theory Analysis Reveals How Sickle Cell Disease Impacts Neural Networks of Patients with More Severe DiseaseYvonne Datta, Deepika S Darbari, Bin He, ScienceDirect
Abstracts/Posters
- Transcranial Doppler Screening in Children with Sickle Cell Anemia Is Feasible in Central India and Reveals High Risk of StrokeDeepika S. Darbari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Pria...Deepika S. Darbari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- ASH Announces 2021 ASH Honorific Award Recipients, 2021 ASH Annual Meeting Registration Now Open, and MoreAugust 2nd, 2021
- ASH to Present Honorific AwardsJuly 19th, 2021
- Deepika Darbari, M.D., Receives the 2021 ASH Award for Leadership in Promoting DiversityJune 30th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: